Details for New Drug Application (NDA): 017533

✉ Email this page to a colleague

NDA 017533 describes KLONOPIN, which is a drug marketed by Cheplapharm and Roche and is included in two NDAs. It is available from one supplier. Additional details are available on the KLONOPIN profile page.

The generic ingredient in KLONOPIN is clonazepam. There are ten drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the clonazepam profile page.

Summary for 017533

Tradename:	KLONOPIN
Applicant:	Cheplapharm
Ingredient:	clonazepam
Patents:	0

Pharmacology for NDA: 017533

Medical Subject Heading (MeSH) Categories for 017533

Anticonvulsants
GABA Modulators

Suppliers and Packaging for NDA: 017533

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
KLONOPIN	clonazepam	TABLET;ORAL	017533	NDA	H2-Pharma, LLC	61269-605	61269-605-10	100 TABLET in 1 BOTTLE, PLASTIC (61269-605-10)
KLONOPIN	clonazepam	TABLET;ORAL	017533	NDA	H2-Pharma, LLC	61269-610	61269-610-10	100 TABLET in 1 BOTTLE, PLASTIC (61269-610-10)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	0.5MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	1MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	2MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Expired US Patents for NDA 017533

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cheplapharm	KLONOPIN	clonazepam	TABLET;ORAL	017533-001	Approved Prior to Jan 1, 1982	⤷ Subscribe	⤷ Subscribe
Cheplapharm	KLONOPIN	clonazepam	TABLET;ORAL	017533-003	Approved Prior to Jan 1, 1982	⤷ Subscribe	⤷ Subscribe
Cheplapharm	KLONOPIN	clonazepam	TABLET;ORAL	017533-002	Approved Prior to Jan 1, 1982	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.